← Leaderboards
Ravikumar N Majeti
University Of Alabama In Tuscaloosa
$5,267,104
Attributed
$8,603,626
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,603,626 · 5
By mechanism
R01$8,603,626 · 5
Top collaborators
- Meenakshi Arora11 shared
- Raghu Ganugula4 shared
- Dhaval K Shah4 shared
Most similar at University Of Alabama In Tuscaloosa
Same institution · by research overlap
- Meenakshi Arora$1,991,584
- Chao Zhao$2,924,887
Others in their field
Other Emerging Leaders on “Nanoparticle”
- Bala Raja · Luminostics, Inc.$28,624,460
- Scott Fry$21,470,000
- Jay Evans · University Of Montana$20,430,088
- Neil King · University Of Washington$14,428,723
- Norbert Pardi · University Of Pennsylvania$12,463,043
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$12,343,878
Research focus
NanoparticleReceptorPharmaceutical PreparationsDoseOralTfrc GeneLigandsBiological AvailabilityDensityRegimenNanosystemsPerformanceTransferrinMediatingDrug Delivery SystemsIntestinesIn VivoPolyestersLengthEncapsulatedSurfaceSide EffectPolymersNucleosome Core Particle
Grant awards (25)
Engineering the next generation nanoparticle-cyclosporine A therapy in lupus$443,846
R01 · FY2025 · AI · contact PI
Polyesters with controlled topologies for probing transcytosis at the gut-blood barrier$367,937
R01 · FY2025 · GM · contact PI
Urolithin A nanoparticle therapy for acute kidney injury$323,152
R01 · FY2025 · DK · contact PI
Engineering the next generation nanoparticle-cyclosporine A therapy in lupus$448,982
R01 · FY2024 · AI · contact PI
Polyesters with controlled topologies for probing transcytosis at the gut-blood barrier$326,110
R01 · FY2024 · GM · contact PI
Urolithin A nanoparticle therapy for acute kidney injury$310,226
R01 · FY2024 · DK · contact PI
Proposal for Administrative supplement to Purchase NanoSight Pro$171,763
R01 · FY2024 · GM · contact PI
Oral delivery of insulin using ligand-directed nanoparticles that do not compete with physiological ligands$372,500
R01 · FY2023 · DK · contact PI
Polyesters with controlled topologies for probing transcytosis at the gut-blood barrier$328,441
R01 · FY2023 · GM · contact PI
Urolithin A nanoparticle therapy for acute kidney injury$323,152
R01 · FY2023 · DK · contact PI
Engineering the next generation nanoparticle-cyclosporine A therapy in lupus$450,986
R01 · FY2022 · AI · contact PI
Oral delivery of insulin using ligand-directed nanoparticles that do not compete with physiological ligands$372,500
R01 · FY2022 · DK · contact PI
Urolithin A nanoparticle therapy for acute kidney injury$323,152
R01 · FY2022 · DK · contact PI
Systemic anti-inflammatory therapy to prevent or delay diabetic cataracts and treat post-surgical inflammation$85,419
R01 · FY2022 · EY · contact PI
Engineering the next generation nanoparticle-cyclosporine A therapy in lupus$467,374
R01 · FY2021 · AI · contact PI
Oral delivery of insulin using ligand-directed nanoparticles that do not compete with physiological ligands$372,500
R01 · FY2021 · DK · contact PI
Systemic anti-inflammatory therapy to prevent or delay diabetic cataracts and treat post-surgical inflammation$360,163
R01 · FY2021 · EY · contact PI
Urolithin A nanoparticle therapy for acute kidney injury$323,152
R01 · FY2021 · DK · contact PI
Engineering the next generation nanoparticle-cyclosporine A therapy in lupus$488,039
R01 · FY2020 · AI · contact PI
Oral delivery of insulin using ligand-directed nanoparticles that do not compete with physiological ligands$378,125
R01 · FY2020 · DK · contact PI
Systemic anti-inflammatory therapy to prevent or delay diabetic cataracts and treat post-surgical inflammation$371,250
R01 · FY2020 · EY · contact PI
Engineering the next generation nanoparticle-cyclosporine A therapy in lupus$81,107
R01 · FY2020 · AI · contact PI
Systemic anti-inflammatory therapy to prevent or delay diabetic cataracts and treat post-surgical inflammation$371,250
R01 · FY2019 · EY · contact PI
Systemic anti-inflammatory therapy to prevent or delay diabetic cataracts and treat post-surgical inflammation$371,250
R01 · FY2018 · EY · contact PI
Systemic anti-inflammatory therapy to prevent or delay diabetic cataracts and treat post-surgical inflammation$371,250
R01 · FY2017 · EY · contact PI